b5media.com

Advertise with us

Enjoying this blog? Check out the rest of the Health & Wellness Channel Subscribe to this Feed

Alzheimer’s Notes

Alzheimer’s News From Around the World.

by Liz Lewis on February 29th, 2008

Intravenous Immunoglobulin Treatment is Associated with a Reduced Risk of Developing Alzheimer’s Disease and Related Disorders - “The risk of developing Alzheimer’s Disease and Related Disorders (ADRD) may be reduced by about 40 percent in patients previously treated with intravenous immunoglobulin (IVIG) according to a study presented today at the 10th International Hong Kong/Springfield Pan-Asian Symposium on Advances in Alzheimer Therapy…” (more)

New device can detect early symptoms, delay progression of Alzheimer’s - “Researchers say there is now a new device that can help doctors detect memory loss early on, and maybe prevent the progression of Alzheimer’s disease…” (more)

Ginkgo Biloba Might Not Preserve Memory in Octogenarians - “Ginkgo biloba, the popular herbal supplement widely promoted as a memory enhancer, offered no clear-cut protection against memory loss in octogenarians, a new study shows…” (more)

Cancer-related Protein May Play Key Role In Alzheimer’s Disease - “The cancer-related protein Akt may profoundly influence the fate of the tau protein, which forms bundles of tangled nerve cell fibers in the brain associated with Alzheimer’s disease, reports a new study led by researchers at the University of South Florida and the Mayo Clinic in Jacksonville, FL…” (more)

Memantine Improves Communication Abilities in Patients With Moderate-to-Severe Alzheimer’s Disease: Presented at AAT - “Memantine significantly improved naming ability and functional communication in donepezil-treated patients with moderate-to-severe Alzheimer’s disease (AD) compared with placebo…” (more)

POSTED IN: General, News, Online Resources, Research, World

0 opinions for Alzheimer’s News From Around the World.

  • No one has left a comment yet. You know what this means, right? You could be first!

Have an opinion? Leave a comment: